Prosztatarák: vizsgálatok itt: Svédország
38 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 11.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleStudy of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)
- Where
- Goteborg, Solna, Uppsala
- Életkor
- 18 év and over
- People
- 1310 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06136624 · EU 2023-504899-25-00 - 3. fázisTaking peopleA Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.
- Where
- Stockholm
- Életkor
- 18 év and over
- People
- 900 worldwide
- Run by
- Pfizer
See details and how to joinNCT06629779 · EU 2024-511652-40-00 - 3. fázisTaking peopleA Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
- Where
- Malmo, Solna, Stockholm, Uppsala
- Életkor
- 18 év and over
- People
- 1440 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06925737 · EU 2024-517423-40-00 - 1/2. fázisTaking peopleStudy to assess the safety and efficacy of the SpectraCure P18 System
- Where
- Malmo
- Életkor
- 18 év and over
- People
- 26 worldwide
- Run by
- SpectraCure AB (publ)
See details and how to join2022-502285-24-00 · EU 2022-502285-24-00 - 3. fázisTaking peopleA Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
- Where
- Solna, Uppsala
- Életkor
- 18 év and over
- People
- 1314 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06136650 · EU 2023-504957-11-00 - No phaseTaking peopleA Study to Learn How Men With Advanced Prostate Cancer Respond to Treatment With Darolutamide and Hormone Therapy, With or Without Chemotherapy, in Real-world Medical Practice
- Where
- Many Locations
- Életkor
- 18 év and over
- People
- 1600 worldwide
- Run by
- Bayer
See details and how to joinNCT07344779 - 3. fázisTaking peopleAZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)
- Where
- Stockholm, Umeå
- Életkor
- 18 év and over
- People
- 670 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07611110 - No phaseTaking peopleThe Case of "Triple" Versus "Double" Therapy for Patients With High Volume Metastatic Hormone Sensitive Prostate Cancer
- Where
- Uppsala
- Életkor
- 18 év and over
- People
- 1400
- Run by
- Uppsala University
See details and how to joinNCT06446401 - 3. fázisTaking peopleA Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation
- Where
- Goteborg, Malmo, Solna, Stockholm, Umea, Uppsala
- Életkor
- 18 év and over
- People
- 700 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06952803 · EU 2024-513586-39-00 - 1/2. fázisTaking peopleStudy of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies
- Where
- Lund, Stockholm
- Életkor
- 18 év to 130 év
- People
- 695 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT05417594 · EU 2023-504984-17-00 - No phaseTaking peopleReduce Sedentary Behavior During Cancer Treatment - the RedSedCan Study
- Where
- Uppsala, Västerås
- Életkor
- 18 év and over
- People
- 210
- Run by
- Mälardalen University
See details and how to joinNCT06719206 - 3. fázisTaking peopleImmediate Curative vs Conservative Treatment in Older Men With M0, High-risk Prostate Cancer
- Where
- Falun, Gothenburg, Helsingborg, Örebro, Östersund, Stockholm, Umeå, Uppsala
- Életkor
- 75 év and over
- People
- 980 worldwide
- Run by
- Sven Löffeler
See details and how to joinNCT05448547 - 2. fázisNot yet taking people in SvédországA phase II, single arm two-phase, clinical study of individually adapted systemic radioligand therapy with 177Lu-PSMA I&T for patients with metastatic, castration-resistant prostate cancer
- Where
- Uppsala
- Életkor
- 18 év and over
- People
- 80
- Run by
- Region Uppsala
See details and how to join2026-527110-23-00 · EU 2026-527110-23-00 - 1. fázisTaking peopleFirst-in-human Study of 225Ac-PSMA-Trillium (BAY 3563254) in Participants With Advanced Metastatic Castration-resistant Prostate Cancer (mCRPC)
- Where
- Goteborg, Lund, Solna, Uppsala
- Életkor
- 18 év and over
- People
- 198 worldwide
- Run by
- Bayer
See details and how to joinNCT06217822 · EU 2023-507486-26-00 - 3. fázisTaking peopleCYPENZA - A prospective cohort trial on antiandrogens influences on the pharmacokinetics of corticosteroids.
- Where
- Umea
- Életkor
- 18 év and over
- People
- 30
- Run by
- Region Vaesterbotten
See details and how to join2025-520571-66-00 · EU 2025-520571-66-00 - 4. fázisTaking peopleLong-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer
- Where
- Goteborg, Lund, Solna
- Életkor
- 18 év to 100 év
- People
- 700 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT05803941 · EU 2023-503208-94-00 - 2. fázisTaking peopleSafety and Diagnostic Performance of uPAR PET Imaging in Localised, Untreated Prostate Cancer
- Where
- Gothenburg, Lund
- Életkor
- 18 év and over
- People
- 168 worldwide
- Run by
- Curasight
See details and how to joinNCT06474806 · EU 2023-507111-35-00 - 2. fázisTaking peopleProstate Androgen Response Investigation Using a Stratification BIOmarker; Predicting Prostate Cancer Downstaging by Neoadjuvant Darolutamide With PCAI ImmunoScore
- Where
- Goteborg, Solna
- Életkor
- 18 év and over
- People
- 100
- Run by
- Region Stockholm
See details and how to joinNCT07617272 · EU 2025-520639-17-00 - No phaseTaking peopleInternational Registry for Men With Advanced Prostate Cancer (IRONMAN)
- Where
- Malmö, Örebro, Umeå
- Életkor
- 21 év and over
- People
- 5000 worldwide
- Run by
- Prostate Cancer Clinical Trials Consortium
See details and how to joinNCT03151629 - 1/2. fázisTaking peopleClinical Study to Assess the Safety and Efficacy of the SpectraCure P18 System
- Where
- Malmö
- Életkor
- 18 év and over
- People
- 66 worldwide
- Run by
- SpectraCure AB
See details and how to joinNCT03067051 - 3. fázisTaking peopleADT +/- Darolutamide in de Novo Metastatic Prostate Cancer Patients With Vulnerable Functional Ability (PEACE6-Vulnerable)
- Where
- Gothenburg, Malmö
- Életkor
- 18 év and over
- People
- 300 worldwide
- Run by
- UNICANCER
See details and how to joinNCT04916613 · EU 2022-502425-18-00 - No phaseTaking peopleAI-based Measurements of Tumour Burden in PSMA PET-CT
- Where
- Lund, Malmö
- Életkor
- 20 év to 120 év
- People
- 1500
- Run by
- Elin Tragardh
See details and how to joinNCT06363435 - No phaseTaking peopleMetastasis Directed Stereotactic Body Radiotherapy for Oligo Metastatic Hormone Sensitive Prostate Cancer
- Where
- Jönköping, Lund, Orebro, Stockholm, Umeå
- Életkor
- 18 év and over
- People
- 118
- Run by
- Karin Soderkvist
See details and how to joinNCT04983095 - No phaseTaking peopleLymphedema After Urologic Surgery
- Where
- Gothenburg, Örebro
- Életkor
- 18 év and over
- People
- 400
- Run by
- Vastra Gotaland Region
See details and how to joinNCT05264337 - No phaseTaking peoplePersonalized Radiotherapy for Biochemical Recurrence of Prostate Cancer After Prostatectomy.
- Where
- Jönköping, Kalmar, Lund
- Életkor
- 18 év and over
- People
- 374
- Run by
- Lund University Hospital
See details and how to joinNCT04858880